Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Upcoming Events

Calendar Review
Recent Advances in the Development of BRAF and Other Ras/MAPK Inhibitors
Date: 5/8/2012
Time: 2:00 PM - 5:00 PM
Cost: Free
Location: BSRB Room 154
Los Angeles, California 90095

JCCC Seminar 

Schedule of events:

2:00 PM – 2:35 PM Antoni Ribas, M.D., Ph.D.
“Combining BRAF targeted therapy and immunotherapy”

2:35 PM – 2:50 PM Edward Garon, M.D.
“Role for MEK inhibition with selumetinib in KRAS mutant non-small cell lung cancer”

2:50 PM – 3:05 PM John Colicelli, Ph.D.
“New insights into RAS regulation: dimerization and post translational modification”

3:05 PM – 3:30 PM Coffee Break

3:30 PM – 4:00 PM Roger Lo, M.D., Ph.D.
“How melanoma escapes from BRAF inhibitors”

4:00 PM – 4:20 PM Thomas Graeber, Ph.D. and Hsian-Rong Tseng, Ph.D.
“Technologies for BRAF discovery & Diagnostics: Phosphoproteomic profiling and microfluidic devices”

4:20 PM – 4:35 PM Fuyu Tamanoi, Ph.D.
“Ras inhibitors”

Light Refreshments Served

Sponsored by the JCCC Signal Transduction & Therapeutics Program